Clinical Role - Retail

Pharmacy Times® is the most trusted resource as it pertains to providing the latest industry news and information to retail pharmacists and reaches more than 200,000 total pharmacy professionals.

HIV
The study results showed that cabotegravir was 89% more effective than daily oral FTC/TDF for preexposure prophylaxis (PrEP).
In a recent letter sent to President Biden, ASHP and more than 50 other health systems and provider organizations requested that the president activate federal resources to establish mass COVID-19 vaccination sites.
 
mask
During the pandemic, it is important to implement policies and practices that take care of employees.
Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how the COVID-19 pandemic has reinforced pharmacists’ purpose of championing the health of every community.
Pharmacy Times® interviewed Thomas D’Angelo, RPh, president of the Pharmacists Society of the State of New York, on how independent pharmacies may be well-positioned to assist in the administration of COVID-19 vaccines.
The perception of creativity has been limited merely to art and innovation, neglecting one of the main sectors that strives for this: education.
 
The increased risk may be due to changes in the brain’s dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia.
 
High blood pressure may be an accelerant of cognitive decline in middle-aged and older adults, according to research published in Hypertension.
A new study published in Experimental Physiology suggests that taking temperature readings of a person’s fingertip and eye would give a significantly better and more reliable reading and help identify those with fever compared to a full body scan.
The drop is the largest single-year decline in life expectancy in 40 years and is the lowest estimate since 2003.
vaccine
They have maintained delivery of critical health services to patients, Including those at greater risk for COVID-19–related complications.
Limitations of the study included the sample size of the participants and a gender imbalance across the groups, with more women randomized to bimagrumab and more men to the placebo.